Changeflow GovPing Healthcare & Life Sciences Skin Barrier Film System Patent Application
Routine Notice Added Draft

Skin Barrier Film System Patent Application

Email

Summary

The USPTO has published a new patent application, US20260083684A1, for a skin barrier film system. The application details a system comprising a film layer, adhesive, impregnated treatment, and a removable layer, designed to accommodate patient physical attributes. The filing date was September 24, 2025.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The United States Patent and Trademark Office (USPTO) has published a new patent application, US20260083684A1, for a skin barrier film system. The application, filed on September 24, 2025, by inventor Michael T. Stanek, describes a system including a film layer, an adhesive, an impregnated treatment, and a removable layer. The film layer is designed to conform to a patient's physical attributes, with the adhesive and treatment layers coupled to it, and a removable layer protecting the adhesive.

This publication represents a new patent application and does not impose any immediate regulatory obligations or compliance deadlines on regulated entities. However, it signals potential future innovation and intellectual property in the area of skin barrier technologies, which may be relevant for pharmaceutical and medical device manufacturers in their research and development strategies. Companies operating in this space should be aware of emerging patent filings that could impact their product pipelines or competitive landscape.

Archived snapshot

Mar 26, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

SKIN BARRIER

Application US20260083684A1 Kind: A1 Mar 26, 2026

Inventors

Michael T. Stanek

Abstract

A skin barrier film system includes a film layer, an adhesive, an impregnated treatment and a removable layer. The film layer is shaped to accommodate a physical attribute of a patient. The adhesive is applied to at least part of the film layer. The impregnated treatment layer is coupled to the film layer. The removable layer is removably coupled to the adhesive, the film layer and/or the impregnated treatment layer.

CPC Classifications

A61K 9/7084

Filing Date

2025-09-24

Application No.

19338654

View original document →

Named provisions

Abstract Inventors

Get daily alerts for USPTO Patent Applications - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260083684A1

Who this affects

Applies to
Drug manufacturers Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Drug Formulation Medical Device Design
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Product Development
Topics
Medical Devices Product Development

Get alerts for this source

We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!